The First Line of Defense: Keep Rodents Out
When it comes to hantavirus, the most powerful weapon is surprisingly low-tech: prevent rodents from sharing our spaces. Since the virus spreads mainly through urine, feces, and saliva from infected rodents, cutting those contacts dramatically reduces risk.
Effective prevention starts at home, work, and camp. That means sealing cracks and holes where mice and rats can enter, disposing of nests, and using traps or poisons to reduce populations in human-frequented areas. Even traditional measures like keeping cats as natural predators can play a role in controlling rodent numbers.
When cleaning areas with rodent droppings, the danger lies in stirring up dust. Hantaviruses can remain infectious for two to three days at room temperature, and disturbing dried excreta can aerosolize viral particles. Public health advice emphasizes wet cleaning methods and protective gear rather than dry sweeping.
Vaccines: Successes and Gaps
On the vaccine front, the world presents a mixed picture. In China and South Korea, whole-virus inactivated bivalent vaccines against Hantaan and Seoul viruses are already in use. Combined with other preventive measures, these vaccines have significantly reduced infections, showing that immunization can tame at least part of the hantavirus threat.
Beyond these, researchers have explored four main vaccine strategies:
- DNA vaccines that target key parts of the viral genome (the M and S segments)
- Subunit vaccines that use individual viral proteins, such as the Gn, Gc, and N proteins
- Viral vector vaccines, where harmless carrier viruses are engineered to display hantavirus proteins
- Virus-like particle vaccines, which mimic the virus structure but contain no genetic material
Of these, only DNA vaccines have advanced into clinical trials. The others remain in experimental or pre-clinical stages.
A Critical Missing Piece: Andes Virus
Even with these advances, there are glaring gaps. As of 2026, there is no vaccine for Andes virus, the only hantavirus known to spread between humans. This leaves South America, and any region connected by travel, vulnerable to outbreaks like those seen in 2005, 2019, and on the MV Hondius cruise ship.
Treatment: Support More Than Cure
For those who do become infected, medical care focuses mostly on supporting the body through the storm. Patients with severe disease are often hospitalized, receive oxygen therapy and mechanical ventilation to get them through the acute pulmonary phase, and may require dialysis if the kidneys fail or platelet transfusions to counteract bleeding.
The antiviral drug ribavirin may help in HFRS if given early, but its effectiveness — especially against HPS — remains uncertain. Experimental immunotherapy using neutralizing human antibodies has been tested only in animals, with no controlled clinical trials in humans yet.
A Practical Takeaway
Hantaviruses have no widely available cure and, for many strains, no vaccine. That makes the most reliable defense surprisingly simple: keep rodents out, treat any droppings as infectious, and respect the invisible risks in dusty, enclosed spaces. In the battle against this stealthy virus, prevention still matters more than anything that can be done once infection takes hold.